TY - JOUR
T1 - β-catenin promotes endothelial survival by regulating eNOS activity and flow-dependent anti-apoptotic gene expression
AU - Tajadura, Virginia
AU - Haugsten Hansen, Marie
AU - Smith, Joy
AU - Charles, Hannah
AU - Rickman, Matthew
AU - Farrell-Dillon, Keith
AU - Claro, Vasco
AU - Warboys, Christina
AU - Ferro, Albert
PY - 2020/6/30
Y1 - 2020/6/30
N2 - Increased endothelial cell apoptosis is associated with the development of atherosclerotic plaques that develop predominantly at sites exposed to disturbed flow. Strategies to promote endothelial cell survival may therefore represent a novel therapeutic approach in cardiovascular disease. Nitric oxide (NO) and β-catenin have both been shown to promote cell survival and they interact in endothelial cells as we previously demonstrated. Here we investigated the physiological role of β-catenin as a mediator of NO-induced cell survival in endothelial cells. We found that β-catenin depleted human umbilical vein endothelial cells (HUVEC) stimulated with pharmacological activators of endothelial NO synthase (eNOS) showed a reduction in eNOS phosphorylation (Ser1177) as well as reduced intracellular cyclic guanosine monophosphate (cGMP) levels compared to control cells in static cultures. In addition, β-catenin depletion abrogated the protective effects of the NO donor, SNAP, during TNFα- and H2O2-induced apoptosis. Using an orbital shaker to generate shear stress, we confirmed eNOS and β-catenin interaction in HUVEC exposed to undisturbed flow (UF) and disturbed flow (DF) and showed that β-catenin depletion reduced eNOS phosphorylation. β- catenin depletion promoted apoptosis exclusively in HUVEC exposed to DF as did inhibition of soluble guanylate cyclase (sGC) or β-catenin transcriptional activity. The expression of the pro-survival genes, Bcl-2 and survivin was also reduced following inhibition of β-catenin transcriptional activity, as was the expression of eNOS. In conclusion, our data demonstrate that β-catenin is a positive regulator of eNOS activity and cell survival in human endothelial cells. sGC activity and β-catenin-dependent transcription of Bcl-2, survivin, BIRC3 and eNOS are essential to maintain cell survival in endothelial cells under DF.
AB - Increased endothelial cell apoptosis is associated with the development of atherosclerotic plaques that develop predominantly at sites exposed to disturbed flow. Strategies to promote endothelial cell survival may therefore represent a novel therapeutic approach in cardiovascular disease. Nitric oxide (NO) and β-catenin have both been shown to promote cell survival and they interact in endothelial cells as we previously demonstrated. Here we investigated the physiological role of β-catenin as a mediator of NO-induced cell survival in endothelial cells. We found that β-catenin depleted human umbilical vein endothelial cells (HUVEC) stimulated with pharmacological activators of endothelial NO synthase (eNOS) showed a reduction in eNOS phosphorylation (Ser1177) as well as reduced intracellular cyclic guanosine monophosphate (cGMP) levels compared to control cells in static cultures. In addition, β-catenin depletion abrogated the protective effects of the NO donor, SNAP, during TNFα- and H2O2-induced apoptosis. Using an orbital shaker to generate shear stress, we confirmed eNOS and β-catenin interaction in HUVEC exposed to undisturbed flow (UF) and disturbed flow (DF) and showed that β-catenin depletion reduced eNOS phosphorylation. β- catenin depletion promoted apoptosis exclusively in HUVEC exposed to DF as did inhibition of soluble guanylate cyclase (sGC) or β-catenin transcriptional activity. The expression of the pro-survival genes, Bcl-2 and survivin was also reduced following inhibition of β-catenin transcriptional activity, as was the expression of eNOS. In conclusion, our data demonstrate that β-catenin is a positive regulator of eNOS activity and cell survival in human endothelial cells. sGC activity and β-catenin-dependent transcription of Bcl-2, survivin, BIRC3 and eNOS are essential to maintain cell survival in endothelial cells under DF.
U2 - 10.1038/s41419-020-2687-6
DO - 10.1038/s41419-020-2687-6
M3 - Article
SN - 2041-4889
VL - 11
JO - Cell Death & Disease
JF - Cell Death & Disease
M1 - 493
ER -